BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 31109456)

  • 1. Role of iron metabolism in heart failure: From iron deficiency to iron overload.
    Zhang H; Zhabyeyev P; Wang S; Oudit GY
    Biochim Biophys Acta Mol Basis Dis; 2019 Jul; 1865(7):1925-1937. PubMed ID: 31109456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of mitochondrial and systemic iron levels in heart failure pathology.
    Lupu M; Tudor DV; Filip GA
    Heart Fail Rev; 2019 Sep; 24(5):647-659. PubMed ID: 31016425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Females Are Protected From Iron-Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress.
    Das SK; Patel VB; Basu R; Wang W; DesAulniers J; Kassiri Z; Oudit GY
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28115312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of iron metabolism in cardiovascular diseases: From iron deficiency to iron overload.
    Bi Y; Ajoolabady A; Demillard LJ; Yu W; Hilaire ML; Zhang Y; Ren J
    Biochem Pharmacol; 2021 Aug; 190():114661. PubMed ID: 34157296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.
    Gutschow P; Schmidt PJ; Han H; Ostland V; Bartnikas TB; Pettiglio MA; Herrera C; Butler JS; Nemeth E; Ganz T; Fleming MD; Westerman M
    Haematologica; 2015 Feb; 100(2):167-77. PubMed ID: 25425686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiomyopathy associated with iron overload: how does iron enter myocytes and what are the implications for pharmacological therapy?
    Wijarnpreecha K; Kumfu S; Chattipakorn SC; Chattipakorn N
    Hemoglobin; 2015; 39(1):9-17. PubMed ID: 25572185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron in Health and Disease: An Update.
    Lal A
    Indian J Pediatr; 2020 Jan; 87(1):58-65. PubMed ID: 31520313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia in heart failure: association of hepcidin levels to iron deficiency in stable outpatients.
    Weber CS; Beck-da-Silva L; Goldraich LA; Biolo A; Clausell N
    Acta Haematol; 2013; 129(1):55-61. PubMed ID: 23147477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron Homeostasis in Health and Disease.
    Gozzelino R; Arosio P
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26805813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapy.
    Das SK; Zhabyeyev P; Basu R; Patel VB; Dyck JRB; Kassiri Z; Oudit GY
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29208771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Evaluation of Iron Deficiency and Iron Overload.
    Gattermann N; Muckenthaler MU; Kulozik AE; Metzgeroth G; Hastka J
    Dtsch Arztebl Int; 2021 Dec; 118(49):847-856. PubMed ID: 34755596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update.
    Gordan R; Wongjaikam S; Gwathmey JK; Chattipakorn N; Chattipakorn SC; Xie LH
    Heart Fail Rev; 2018 Sep; 23(5):801-816. PubMed ID: 29675595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice.
    Sebastiani G; Pantopoulos K
    Metallomics; 2011 Oct; 3(10):971-86. PubMed ID: 21901209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of erythroferrone in iron metabolism: From experimental results to pathogenesis].
    Vallet N;
    Rev Med Interne; 2018 Mar; 39(3):178-184. PubMed ID: 28666715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron metabolism: iron deficiency and iron overload.
    Andrews NC
    Annu Rev Genomics Hum Genet; 2000; 1():75-98. PubMed ID: 11701625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of iron overload on mitochondrial function, mitochondrial dynamics, and ferroptosis in cardiomyocytes.
    Sumneang N; Siri-Angkul N; Kumfu S; Chattipakorn SC; Chattipakorn N
    Arch Biochem Biophys; 2020 Feb; 680():108241. PubMed ID: 31891670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prooxidant mechanisms in iron overload cardiomyopathy.
    Cheng CF; Lian WS
    Biomed Res Int; 2013; 2013():740573. PubMed ID: 24350287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Iron deficiency and overload. Implications in oxidative stress and cardiovascular health].
    Toxqui L; De Piero A; Courtois V; Bastida S; Sánchez-Muniz FJ; Vaquero MP
    Nutr Hosp; 2010; 25(3):350-65. PubMed ID: 20593115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Getting to the "Heart" of Cardiac Disease by Decreasing Mitochondrial Iron.
    Chang HC; Shapiro JS; Ardehali H
    Circ Res; 2016 Nov; 119(11):1164-1166. PubMed ID: 28051781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of cellular iron metabolism.
    Chua AC; Graham RM; Trinder D; Olynyk JK
    Crit Rev Clin Lab Sci; 2007; 44(5-6):413-59. PubMed ID: 17943492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.